Comparison of Continuous and Interrupted Suturing Techniques in Ventricular Septal Defect Closure
Background: Our goal is to evaluate postoperative outcomes of continuous versus interrupted suturing techniques in ventricular septal defect (VSD) closure surgery.
Methods: The study included 286 patients with isolated VSD who underwent VSD closure surgery between June 2010 and April 2017. VSD closure was performed by using the interrupted suturing technique in group 1 (n = 74, 25.9%) and the continuous suturing technique in group 2 (n = 212, 74.1%). The groups were compared in terms of mortality and rates of clinical morbidities such as infection and complete atrioventricular (AV) block.
Results: Early mortality occurred in 3 cases in group 1 (4.0%) and 5 cases in group 2 (2.3%). There was no late mortality in either group. One patient from both groups required extracorporeal membrane oxygenation (ECMO) at postoperative 48 hours. Five patients in group 1 (6.8%) and 11 patients in group 2 (5.2%) developed complete AV block postoperatively and received permanent pacemaker implants.
Conclusion: Complication rates were similar between the patient groups operated on by using continuous and interrupted suturing techniques in our study, suggesting that neither technique is superior for VSD closure surgery.
Anderson BR, Stevens KN, Nicolson SC, et al. 2013. Contemporary outcomes of surgical ventricular septal defect closure. J Thorac Cardiovasc Surg 145:641-7.
Atik FA, Afiune JY, Caneo LF. 2009. Autologous pericardium patch aneurysm after ventricular septal defect closure and arterial switch operation. J Card Surg 24:479-80.
Bahtiyar MO, Dulay AT, Weeks BP, Friedman AH, Copel JA. 2008. Prenatal course of isolated muscular ventricular septal defects diagnosed only by color Doppler sonography: single-institution experience. J Ultrasound Med 27:715-20.
Bol Raap G, Meijboom FJ, Kappetein AP, Galema TW, Yap SC, Bogers AJ. 2007. Long-term follow-up and quality of life after closure of ventricular septal defect in adults. Eur J Cardiothorac Surg 32:215-9.
Caimmi PP, Grossini E, Kapetanakis EI, et al. 2010. Double patch repair through a single ventriculotomy for ischemic ventricular septal defects. Ann Thorac Surg 89:1679-81.
Erdil N, Birincioğlu CL, İşcan HZ, et al. 2000. İzole ventriküler septal defekt cerrahi tedavisinde erken ve geç dönem sonuçlar. [Early and late term results in surgical treatment of isolated ventricular septal defects]. T Klin J Cardiol 13:83-90. Turkish.
Gaynor JW, O’Brien JE Jr, Rychik J, Sanchez GR, DeCampli WM, Spray TL. 2001. Outcome following tricuspid valve detachment for ventricular septal defect closure. Eur J Cardiothorac Surg 19:279-82.
Grabitz RG, Joffers MR, Collins-Nakai RL. 1988. Congenital heart disease: incidence in the first year of life. The Alberta heritage pediatric cardiology program. Am J Epidemiol 128:381-8.
Hoffman JI, Kaplan S, Liberthson RR. 2004. Prevalence of congenital heart disease. Am Heart J 147:425-39.
Mercan AŞ, Saygılı A, Sezgin A, et al. 2001. İnfant ventriküler septal defekt cerrahisinde risk faktörleri. [Risk factors in infant ventricular septal defect surgery]. Turkish J Thorac Cardiovasc Surg 9:149-52. Turkish
Pridjian AK, Pearce FB, Culpepper WS, Williams LC, Van Meter CH, Ochsner JL. 1993. Atrioventricular valve competence after take-down to improve exposure during ventricular septal defect repair. J Thorac Cardiovasc Surg 106:1122-5.
Sim EK, Grignani RT, Wong ML, et al. 1999. Outcome of surgical closure of doubly committed subarterial ventricular septal defect. Ann Thorac Surg 67:736-8.
Stirling GR, Stanley PH, Lillehei CW. 1957. The effects of cardiac bypass and ventriculotomy upon right ventricular function; with report of successful closure of ventricular septal defect by use of atriotomy. Surg Forum 8:433-8.
Tatebe S, Miyamura H, Watanabe H, Suqawara M, Equchi S. 1995. Closure of isolated ventricular septal defect with detachment of the tricuspid valve. J Card Surg 10:564-8.
Tucker EM, Pyles LA, Bass JL, Moller JH. 2007. Permanent pacemaker for atrioventricular conduction block after operative repair of perimembranous ventricular septal defect. J Am Coll Cardiol 50:1196-200.
Tynan M, Anderson RH. Ventricular septal defect. In: Anderson RH, Baker EJ, Macartney FJ, Rigby ML, Shinebourne EA, Tynan M, editors. Paediatric cardiology. Edinburgh: Churchill Livingstone; 2002. p. 983-1014.
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).